Events

Brain Resilience Symposium: Parkinson's Disease

Join the Knight Initiative for Brain Resilience at a symposium on Parkinson's Disease.

Parkinson's Disease (PD) is the second most common neurodegenerative disorder of aging and the most common movement disorder. This symposium invites anybody interested in the science of brain resilience. Renowned experts in the field will share their latest research on PD and help us better understand the remarkable resilience of the human brain. Connect with fellow attendees at a celebratory social gathering after the event.

  • Date: Thursday, January 25, 2024
  • Time: 12:30pm – 6:30pm PST
  • Location: Li Ka Shing Center (LKSC), Paul Berg Hall

Registration is required, register here

Download the agenda here.

We look forward to welcoming you at our Symposium on Parkinson's Disease.

View at Stanford Events

Schedule

  • Registration, coffee and cookies

  • Opening

    Tony Wyss-Coray, Knight Initiative for Brain Resilience Director

  • Clinical background and patient presentation with Q&A

    Kathleen Poston, MD, MS, Professor of Neurology & Neurological Sciences and University Medical Line

  • Rethinking the role of alpha-synuclein aggregation in Parkinson’s disease: from models to novel mechanisms and therapies

    Hilal Lashuel, PhD, Associate Professor of Life Sciences, Director of the Laboratory of Chemical Biology of NeurodegenerationBrain Mind Institute. Swiss Federal Institute of Technology Lausanne, Switzerland

  • Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson's disease

    Shahzad Khan, PhD, Faculty, University of North Carolina at Chapel Hill

  • Mitochondria as signaling organelles in physiology and disease

    Navdeep Chandel, PhD, David W. Cugell Professor of Medicine & Biochemistry and Molecular Genetics

  • Break, coffee and cookies

  • Charting a new path with ASAP

    Ekemini Riley, ASAP Initiative (disease-focused funding agency)

  • Understanding LRRK2 and its role in Parkinson's Disease

    Dario Alessi, University of Dundee

  • Progress toward advancing the National Plan to Address AD/ADRD: implications for the biological diagnosis and staging of AD, PD and other neurodegenerative disorders

    Eliezer Masliah, MD, National Institute of Aging, Director of Neuroscience

  • Closing

    Natasha Hussain, PhD, Knight Initiative for Brain Resilience Associate Director

  • Celebratory social

  • Sponsor

    Knight Initiative for Brain Resilience